California recalls
5268 federal recalls on file affecting California - 1283 California-specific plus 3985 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-07-29FDA-FoodModern Warrior LifeClass INationwideModern Warrior Ready supplement recalled for unapproved ingredients
FDA analysis revealed the presence of unapproved ingredients including tianeptine, 1,4 DMAA, and aniracetam.
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi Xylocaine recalled for particulate matter contamination
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi Xylocaine injection recalled for particulate contamination
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi Naropin recalled for particulate matter
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi lidocaine injection recalled for hair contamination
Presence of Particulate Matter: Hair was found in products
- 2026-07-29FDA-DrugFresenius KabiClass IINationwideFresenius Kabi glycopyrrolate injection recalled for particulate contamination
Presence of Particulate Matter: Hair was found in product
- 2026-07-29FDA-DrugRising PharmaClass IINationwideRising Cyproheptadine Hydrochloride Syrup recalled for precipitate
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility issue
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concern
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Digi Eye recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility risk
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugAscend LaboratoriesClass IINationwideAscend amlodipine-olmesartan tablets recalled for low drug content
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine 125 mcg recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for low potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine recalled for reduced potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine 112 mcg recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for reduced potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugPrecision DoseNot Yet ClassifiedNationwidePrecision Dose glycopyrrolate solution recalled for impurity
Due to an out-of-specification result for an unidentified impurity detected during routine stability testing.
- 2026-07-24FDA-PRSunny PharmtechNationwideSunny Pharmtech Cyclophosphamide recalled for steel particles
July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of particulate matter identified as steel. To date, no adverse events or injuries associated with this pa
Get notified about new California recalls
Free weekly digest. Add California to your profile to filter alerts to your state.
Get the Sunday Brief